Caerus Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.23M Sell
18,563
-22
-0.1% -$2.54K 0.93% 18
2025
Q4
$1.96M Buy
18,585
+2,963
+19% +$278K 0.63% 22
2025
Q3
$1.31M Buy
+15,622
New +$1.29M 0.54% 26
2023
Q2
Sell
-1,963
Closed -$209K 44
2023
Q1
$209K Hold
1,963
0.24% 49
2022
Q4
$218K Buy
+1,963
New +$201K 0.33% 38

Other funds holding MRK

Caerus Investment Advisors's MRK Position: Q1 2026 in Review

Caerus Investment Advisors reduced its Merck (MRK) stake by 0.12% in Q1 2026, selling an estimated $2.54K and leaving 18,563 shares worth $2.23M. The position accounts for 0.93% of the portfolio, ranked #18.

Caerus Investment Advisors first reported a position in MRK in Q4 2022 and has held it in 5 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caerus Investment Advisors held 18,563 shares of Merck worth $2.23M as of Q1 2026.
  • Caerus Investment Advisors sold 22 Merck shares in Q1 2026, an estimated $2.54K.
  • Merck made up 0.93% of Caerus Investment Advisors's portfolio in Q1 2026, its #18 holding.
  • Caerus Investment Advisors first reported a position in Merck in Q4 2022 and has held it in 5 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caerus Investment Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.